Five9, Inc. (FIVN)

Elevation Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,106	1,042	910.49	778.85	609.59	434.91
Revenue Growth (YoY)	14.21%	14.44%	16.90%	27.77%	40.17%	32.59%
Cost of Revenue	494.43	475.44	432.69	367.5	271.1	180.28
Gross Profit	611.38	566.5	477.8	411.35	338.49	254.62
Selling, General & Admin	437.17	431.6	413.01	356.87	282.21	198.18
Research & Development	160.67	164.3	156.58	141.79	106.9	68.75
Operating Expenses	597.85	595.9	569.59	498.67	389.1	266.93
Operating Income	13.54	-29.4	-91.8	-87.32	-50.61	-12.31
Interest Expense	-16.27	-14.81	-7.65	-7.49	-8.03	-28.35
Interest & Investment Income	40.61	46.75	26.8	4.81	-	3.03
Other Non Operating Income (Expenses)	-	-	-	-	-0.01	-
EBT Excluding Unusual Items	37.87	2.53	-72.64	-90	-58.65	-37.62
Merger & Restructuring Charges	-31.77	-21.9	-6.78	-	-	-
Other Unusual Items	-	6.62	-	-0.26	-5.64	-6.96
Pretax Income	6.1	-12.76	-79.42	-90.26	-64.29	-44.58
Income Tax Expense	-2.73	0.04	2.34	4.39	-11.29	-2.45
Net Income	8.83	-12.8	-81.76	-94.65	-53	-42.13
Net Income to Common	8.83	-12.8	-81.76	-94.65	-53	-42.13
Shares Outstanding (Basic)	76	75	72	70	68	64
Shares Outstanding (Diluted)	82	75	72	70	68	64
Shares Change (YoY)	12.03%	3.41%	3.04%	3.57%	5.23%	6.27%
EPS (Basic)	0.12	-0.17	-1.13	-1.35	-0.79	-0.66
EPS (Diluted)	0.11	-0.17	-1.13	-1.35	-0.79	-0.66
Free Cash Flow	142.5	100.78	97.6	36.59	-13.22	36.88
Free Cash Flow Per Share	1.74	1.35	1.35	0.52	-0.20	0.57
Gross Margin	55.29%	54.37%	52.48%	52.81%	55.53%	58.55%
Operating Margin	1.22%	-2.82%	-10.08%	-11.21%	-8.30%	-2.83%
Profit Margin	0.80%	-1.23%	-8.98%	-12.15%	-8.69%	-9.69%
Free Cash Flow Margin	12.89%	9.67%	10.72%	4.70%	-2.17%	8.48%
EBITDA	70.46	23.51	-43.28	-42.65	-11.88	12.78
EBITDA Margin	6.37%	2.26%	-4.75%	-5.48%	-1.95%	2.94%
D&A For EBITDA	56.92	52.91	48.52	44.67	38.73	25.09
EBIT	13.54	-29.4	-91.8	-87.32	-50.61	-12.31
EBIT Margin	1.22%	-2.82%	-10.08%	-11.21%	-8.30%	-2.83%
Advertising Expenses	-	25.4	31.3	28.1	20.8	15.6

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q